Sab Biotherapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$3.22

-0.08 (-2.28%)

As of Sep 28, 10:15 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 16 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +877.0% upside

Low Target $26.29

Average Target $31.41

High Target $48.84

Current Price $3.22

Current
$3.22

Target
$31.41

$26.29 $31.41 avg $48.84

Scenario Analysis

Bear Case

$26.29

717.7%

Low target

Base Case

$31.41

+877.0%

Avg target

Bull Case

$48.84

+1,419.1%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$5.15

-37.6% from high

52-Week Low

$1.85

+73.8% from low

Target vs 52W High

$31.41

+509.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%